HYDERABAD, India, Oct. 1, 2025 -- Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aims to bring high-value, next-generation sequencing (NGS) technologies closer to patients and healthcare providers across the country. By combining AMPATH's extensive diagnostic network with Gene Solutions' expertise in genomics, the partnership will enable more timely,
GUANGZHOU, China, Oct. 1, 2025 -- The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition, organized by Reed Sinopharm Exhibitions, was held from September 26–29 at the Canton Fair Complex in Guangzhou. Covering nearly 160,000 square meters, the event gathered 3,000+ exhibitors from 20 countries and regions, presenting 10,000+ new products to 120,000 professional visitors from over 160 countries. CMEF reaffirmed its role as a globally influential hub for healthcare innovation and high-quality development. Over four decades, CMEF has evolved into a prem
[ 메디채널 김갑성 기자 ] - Total Area of 37,000m2, Enhanced Pharmaceutical Logistics Capacity - TOKYO, Oct. 1, 2025 -- MD Logistics LLC (hereinafter "MD Logistics"), a group company of NIPPON EXPRESS HOLDINGS, INC., completed renovation of the South Area of its largest logistics base in Plainfield, in the U.S. state of Indiana in July. As a result, the entire facility, with a total area of approximately 37,000m2, will begin operating as a cGMP*-compliant facility dedicated to pharmaceutical products. Logo: https://drive.google.com/file/d/1dqm0cxpYamnvMUra1AGXMuGlX932Z353/view
TAIPEI, Oct. 1, 2025 -- Taiwan's leading health management brand, Major Health Management, has been honored with the Excellence Award in Health Technology – Health Examination Platform at the 2025 Health Brand Awards. This award is a highly regarded annual recognition in the health industry, representing professionalism, credibility, and social impact. The accolade not only highlights MJ's 38 years of dedication to preventive medicine, but also reflects its successful integration of big data and health technology in upgrading Taiwan's health examination services. 38 Year
TAIPEI, Oct. 1, 2025 -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world's first Apixaban Oral Dissolving Film (ODF). This submission marks a significant regulatory milestone in TAHO Pharma's mission to bring innovative and accessible therapies to patients worldwide. TAH3311 is an innovative formulation designed to improve the delivery of apixaban, a widely used anticoagulant. Stroke affects more than 15 million people worldwide each year according t
KUALA LUMPUR, Malaysia, Oct. 1, 2025 -- The Minister of Health, Y.B. Datuk Seri Dr. Dzulkefly Ahmad today announced that the selection and evaluation process of finding MHTC new Chief Executive Officer (CEO) is officially concluded with the appointment of Encik Suriaghandi Suppiah effective 29 September 2025. Suriaghandi's career is marked by his ability to lead transformation initiatives, strengthen operations, and drive sustainable growth across diverse sectors. Most recently, he has served as Healthcare Advisor to the Employees Provident Fund (EPF), where he played a pivotal
MELBOURNE, Australia, Sept. 30, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its record-breaking conference presence with 28 company-related abstract presentations at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Barcelona from 4 – 8 October 2025. Dr. David N. Cade, Telix Group Chief Medical Officer, said, "We are pleased to showcase our late-stage and next generation development programs and innovations in MedTech at EANM – the largest gathering of nuclear med
KUALA LUMPUR, Malaysia, Sept. 30, 2025 -- Emagene Life, Asia's leader in functional medicine and longevity, is proud to announce its official international partnership with the Institute for Functional Medicine (IFM), the leading voice for functional medicine for more than 30 years. This landmark collaboration aligns Emagene Life with the confident and competent practice of functional medicine worldwide, combining clinical excellence, education, and partnerships across medical disciplines. Leading the Future of Functional Medicine and Longevity Emagene Life is the first
SHANNAN, China, Oct. 1, 2025 -- Angel Yeast (SH600298), a global leader in yeast and biotechnology, today announced that its subsidiary Xizang Angel Zhufeng Biotechnology Co., Ltd. ("Angel Zhufeng"), located on the Qing-Zang Plateau, has officially commenced operations at the world's first high-altitude probiotic production facility. The state-of-the-art plant has completed its first shipment of the Bifidobacterium lactis XZ-BI36 probiotic powder. "Every stage of production is carried out in oxygen-free conditions—setting a new industry benchmark for qual
TOKYO, Oct. 1, 2025 -- Taiwan Cell Manufacturing Company (tcmc), a state-of-the-art CDMO specializing in cell and gene therapy (CGT) manufacturing, is participating in BioJapan 2025 - Asia's premier biotechnology exhibition – taking place October 8-10 in Yokohama, Japan. At this influential event, tcmc will showcase its world-class CDMO services, foster strategic collaborations, and champion innovation in CAR-T cell therapy and regenerative medicine across Asia and beyond. tcmc is Taiwan's PIC/S GMP-compliant facility dedicated to the commercial manufacturing of genetically mod